Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Moorehead

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Nursing Times|June 10, 2000
Bullets and bombs, cuts and crashesM Whiteside, R Moorehead
International Journal of Oncology|May 18, 2011
Mitochondria as a target for combination cancer-chemotherapyG Singh, R Moorehead
Clinical Chemistry|April 1, 1970
An automated micromethod for determination of serum glucose, wih an improved o-toluidine reagentW R Moorehead, E A Sasse
Clinical Chemistry|April 1, 1975
Letter: Updating coninuous-flow uric acid methodologyW R Moorehead, L M Kasper
Clinical Chemistry|November 1, 1974
2-Amino-2-methyl-1-propanol as the alkalizing agent in an improved continuous-flow cresolphthalein complexone procedure for calcium in serumW R Moorehead, H G Biggs
American Journal of Clinical Pathology|January 1, 1980
High-density lipoprotein cholesterol--a significant bias between methodsJ B Priest, W R Moorehead
Pharmacology & Therapeutics|January 1, 1992
Mitochondrial DNA damage by anticancer agentsG Singh, S M Sharkey, R Moorehead
Journal of Bioenergetics and Biomembranes|August 1, 1997
Mitochondrial contributions to cancer cell physiology: redox balance, cell cycle, and drug resistanceA Dorward, S Sweet, R Moorehead, et al.
Clinical Chemistry|September 1, 1975
Colorimetry of serum cholesterol with use of ferric acetate/uranyl acetate and ferrous sulfate/sulfuric acid reagentsD H Jung, H G Biggs, W R Moorehead
Clinical Chemistry|March 1, 1975
A manual colormetric assay of triglycerides in serumH G Biggs, J M Erikson, W R Moorehead
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Nursing Times|June 10, 2000
Bullets and bombs, cuts and crashesM Whiteside, R Moorehead
International Journal of Oncology|May 18, 2011
Mitochondria as a target for combination cancer-chemotherapyG Singh, R Moorehead
Clinical Chemistry|April 1, 1970
An automated micromethod for determination of serum glucose, wih an improved o-toluidine reagentW R Moorehead, E A Sasse
Clinical Chemistry|April 1, 1975
Letter: Updating coninuous-flow uric acid methodologyW R Moorehead, L M Kasper
Clinical Chemistry|November 1, 1974
2-Amino-2-methyl-1-propanol as the alkalizing agent in an improved continuous-flow cresolphthalein complexone procedure for calcium in serumW R Moorehead, H G Biggs
American Journal of Clinical Pathology|January 1, 1980
High-density lipoprotein cholesterol--a significant bias between methodsJ B Priest, W R Moorehead
Pharmacology & Therapeutics|January 1, 1992
Mitochondrial DNA damage by anticancer agentsG Singh, S M Sharkey, R Moorehead
Journal of Bioenergetics and Biomembranes|August 1, 1997
Mitochondrial contributions to cancer cell physiology: redox balance, cell cycle, and drug resistanceA Dorward, S Sweet, R Moorehead, et al.
Clinical Chemistry|September 1, 1975
Colorimetry of serum cholesterol with use of ferric acetate/uranyl acetate and ferrous sulfate/sulfuric acid reagentsD H Jung, H G Biggs, W R Moorehead
Clinical Chemistry|March 1, 1975
A manual colormetric assay of triglycerides in serumH G Biggs, J M Erikson, W R Moorehead
Pageof 3